Diagnostics of anti-MAG antibody polyneuropathy

D Franciotta; M Gastaldi; Luana Benedetti; Martina Garnero; T Biagioli; Marco Brogi; G Costa; Elisabetta Fadda; F Andreetta; O Simoncini; C Giannotta; E Bazzigaluppi; R Fazio; Roberta Bedin; Diana Ferraro; Sara Mariotto; S Ferrari; E Galloni; Valentina De Riva; E Zardini; A Cortese; E Nobile-Orazio

doi:10.1007/s10072-017-3024-4

Diagnostics of anti-MAG antibody polyneuropathy

D Franciotta, M Gastaldi, Luana Benedetti, Martina Garnero, T Biagioli, Marco Brogi, G Costa, Elisabetta Fadda, F Andreetta, O Simoncini, C Giannotta, E Bazzigaluppi, R Fazio, Roberta Bedin, Diana Ferraro, Sara Mariotto, S Ferrari, E Galloni, Valentina De Riva, E ZardiniA Cortese, E Nobile-Orazio

Research output: Contribution to journal › Article › peer-review

Abstract

This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of Neuroimmunology (AINI) congresses. The main clinical information on anti-MAG antibody polyneuropathy, indications and limits of anti-MAG antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists. © 2017, Springer-Verlag Italia S.r.l.

Original language	English
Pages (from-to)	249-252
Number of pages	4
Journal	Neurological Sciences
Volume	38
Issue number	suppl 2
DOIs	https://doi.org/10.1007/s10072-017-3024-4
Publication status	Published - 2017

Access to Document

10.1007/s10072-017-3024-4

http://www.scopus.com/inward/record.url?scp=85032857392&partnerID=8YFLogxK

Cite this

Franciotta, D., Gastaldi, M., Benedetti, L., Garnero, M., Biagioli, T., Brogi, M., Costa, G., Fadda, E., Andreetta, F., Simoncini, O., Giannotta, C., Bazzigaluppi, E., Fazio, R., Bedin, R., Ferraro, D., Mariotto, S., Ferrari, S., Galloni, E., De Riva, V., ... Nobile-Orazio, E. (2017). Diagnostics of anti-MAG antibody polyneuropathy. Neurological Sciences, 38(suppl 2), 249-252. https://doi.org/10.1007/s10072-017-3024-4

Diagnostics of anti-MAG antibody polyneuropathy. / Franciotta, D ; Gastaldi, M; Benedetti, Luana; Garnero, Martina; Biagioli, T; Brogi, Marco; Costa, G; Fadda, Elisabetta; Andreetta, F ; Simoncini, O ; Giannotta, C; Bazzigaluppi, E; Fazio, R; Bedin, Roberta; Ferraro, Diana; Mariotto, Sara; Ferrari, S; Galloni, E; De Riva, Valentina; Zardini, E ; Cortese, A ; Nobile-Orazio, E.

In: Neurological Sciences, Vol. 38, No. suppl 2, 2017, p. 249-252.

Research output: Contribution to journal › Article › peer-review

Franciotta, D , Gastaldi, M, Benedetti, L, Garnero, M, Biagioli, T, Brogi, M, Costa, G, Fadda, E, Andreetta, F , Simoncini, O , Giannotta, C, Bazzigaluppi, E, Fazio, R, Bedin, R, Ferraro, D, Mariotto, S, Ferrari, S, Galloni, E, De Riva, V, Zardini, E , Cortese, A & Nobile-Orazio, E 2017, 'Diagnostics of anti-MAG antibody polyneuropathy', Neurological Sciences, vol. 38, no. suppl 2, pp. 249-252. https://doi.org/10.1007/s10072-017-3024-4

Franciotta, D ; Gastaldi, M ; Benedetti, Luana ; Garnero, Martina ; Biagioli, T ; Brogi, Marco ; Costa, G ; Fadda, Elisabetta ; Andreetta, F ; Simoncini, O ; Giannotta, C ; Bazzigaluppi, E ; Fazio, R ; Bedin, Roberta ; Ferraro, Diana ; Mariotto, Sara ; Ferrari, S ; Galloni, E ; De Riva, Valentina ; Zardini, E ; Cortese, A ; Nobile-Orazio, E. / Diagnostics of anti-MAG antibody polyneuropathy. In: Neurological Sciences. 2017 ; Vol. 38, No. suppl 2. pp. 249-252.

@article{cef93555d6b745c08363f5249a67cfe4,

title = "Diagnostics of anti-MAG antibody polyneuropathy",

abstract = "This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of Neuroimmunology (AINI) congresses. The main clinical information on anti-MAG antibody polyneuropathy, indications and limits of anti-MAG antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists. {\textcopyright} 2017, Springer-Verlag Italia S.r.l.",

author = "D Franciotta and M Gastaldi and Luana Benedetti and Martina Garnero and T Biagioli and Marco Brogi and G Costa and Elisabetta Fadda and F Andreetta and O Simoncini and C Giannotta and E Bazzigaluppi and R Fazio and Roberta Bedin and Diana Ferraro and Sara Mariotto and S Ferrari and E Galloni and {De Riva}, Valentina and E Zardini and A Cortese and E Nobile-Orazio",

year = "2017",

doi = "10.1007/s10072-017-3024-4",

language = "English",

volume = "38",

pages = "249--252",

journal = "Neurological Sciences",

issn = "1590-1874",

publisher = "Springer-Verlag Italia s.r.l.",

number = "suppl 2",

}

TY - JOUR

T1 - Diagnostics of anti-MAG antibody polyneuropathy

AU - Franciotta, D

AU - Gastaldi, M

AU - Benedetti, Luana

AU - Garnero, Martina

AU - Biagioli, T

AU - Brogi, Marco

AU - Costa, G

AU - Fadda, Elisabetta

AU - Andreetta, F

AU - Simoncini, O

AU - Giannotta, C

AU - Bazzigaluppi, E

AU - Fazio, R

AU - Bedin, Roberta

AU - Ferraro, Diana

AU - Mariotto, Sara

AU - Ferrari, S

AU - Galloni, E

AU - De Riva, Valentina

AU - Zardini, E

AU - Cortese, A

AU - Nobile-Orazio, E

PY - 2017

Y1 - 2017

N2 - This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of Neuroimmunology (AINI) congresses. The main clinical information on anti-MAG antibody polyneuropathy, indications and limits of anti-MAG antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists. © 2017, Springer-Verlag Italia S.r.l.

AB - This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of Neuroimmunology (AINI) congresses. The main clinical information on anti-MAG antibody polyneuropathy, indications and limits of anti-MAG antibody testing, instructions for result interpretation, and an agreed laboratory protocol (Appendix) are reported for the communicative community of neurologists and clinical pathologists. © 2017, Springer-Verlag Italia S.r.l.

U2 - 10.1007/s10072-017-3024-4

DO - 10.1007/s10072-017-3024-4

M3 - Article

VL - 38

SP - 249

EP - 252

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - suppl 2

ER -

Diagnostics of anti-MAG antibody polyneuropathy

Abstract

Access to Document

Fingerprint

Cite this